
Akadeum Life Sciences
Working on the problem of isolating mammalian and bacterial cells from complex mixtures.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $20.0m | Late VC | |
Total Funding | 000k |
Related Content
Akadeum Life Sciences, Inc. specializes in advanced cell separation technology using proprietary microbubble technology. This innovative approach allows for rapid and gentle isolation of cells without the need for magnets, making it a valuable tool for researchers in clinical labs and other biotechnical roles. Akadeum's products are designed to improve the quality and reduce the costs of cell separation processes, which are crucial in various life sciences applications, including culture, PCR, and flow cytometry. The company operates in the biotechnology market and serves a diverse range of clients, including research institutions, clinical laboratories, and corporate partners. Akadeum generates revenue through the sale of its cell isolation products and by partnering with other companies to commercialize its microbubble-based technologies. The business model focuses on continuous innovation and collaboration to enhance cell separation workflows and results.
Keywords: microbubble technology, cell isolation, biotechnology, clinical labs, research institutions, flow cytometry, PCR, cell separation, corporate partnerships, innovation.